Bio-Rad Laboratories BIO Net Income
Discontinued — last reported Q1 '26
Net Income at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's net income?
- Bio-Rad Laboratories (BIO) reported net income of -$527.1M in Q1 2026.
- How has Bio-Rad Laboratories's net income changed year-over-year?
- Bio-Rad Laboratories's net income decreased by 923.6% year-over-year, from $64M to -$527.1M.
- What is the long-term trend for Bio-Rad Laboratories's net income?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's net income has grown at a -35.0% compound annual growth rate (CAGR), from $4.25B to $759.9M.
- What does net income mean?
- The final profit remaining after all expenses and taxes have been paid.
- How do you interpret net income?
- Higher net income signals strong profitability and value creation, whereas a decrease or loss indicates operational challenges or significant non-recurring charges.
- How does net income compare across companies?
- The most common benchmark for profitability; investors compare net income margins across the life sciences and diagnostics sector.